Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis
Maya Abdallah(Baystate Medical Center), Raphaël Szalat(Boston University), Camille V. Edwards(Boston University), Andrew Staron(Boston University), Kimberly A. Bertrand(Université Paris-Sud), J. Mark Sloan(Boston University), Adam Lerner(University of Massachusetts Lowell), Brittany Fuller(Boston University), Fabio Petrocca(Bristol-Myers Squibb (Sweden)), Margaux Dockerty(Boston University), Vaishali Sanchorawala(Boston Medical Center), A.M.K. Godfrey(Boston University), Jasmine Patel(Boston University)
Cited by 2
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550